Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZCCHC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SAMD4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP2K4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRPRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCND3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INO80D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDFY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LUC7L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TADA2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD54L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SVOPL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF222 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL18BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BACH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNLR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST1H2BJ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on